Egypt Liver Cancer Therapeutics Market
is anticipated to register growth with an impressive CAGR in the forecast
period, 2023-2027. The rising incidence of liver cancer has been recorded as
the second leading cause of death after the deaths due to cardiovascular
disorders. Egypt ranks number 2 in the world in terms of deaths caused by
liver cancer. According to the latest report of WHO, in 2020, liver cancer
deaths in Egypt accounted for 24,512 or 4.57% of total deaths. The growing
aging population that is highly prone to such chronic ailments, high
consumption of alcohol, and rising number of smokers are primarily contributing
to the increasing cases of liver cancer. As a result, the high prevalence of
such cases is increasing the demand for liver cancer therapeutics. Liver cancer
is a chronic, progressive, and life-threatening disorder that begins at the
cellular level of the liver. The liver is one of the vital organs in the human
body. Its function is to produce enzymes and bile, which facilitates the
digestion of food. It also produces blood clotting proteins and helps in
purifying the blood by flushing out harmful materials from the body.
Most of the patients do not feel or show
the symptoms related to liver cancer at an early stage, but in later stages,
the patient starts to feel a loss of appetite, rapid weight loss, nausea,
vomiting, abdominal pain, and swelling. Early detection and availability of a
wide range of liver cancer therapeutics help in preventing and treating liver
cancer. Therefore, the demand for liver cancer therapeutics in Egypt is surging
rapidly.
Apart from this, extensive R&D
activities going on in biotechnology and medical science are providing trust to
the market. Moreover, several technological advancements in cancer
therapeutics, such as the introduction of gene therapy and bioartificial liver,
are strengthening the market growth. Furthermore, the increasing investments by
both private and government sectors to upgrade the healthcare infrastructure in
Egypt are opening great growth avenues for the market players. In addition to
this, the growing adoption of smartphones and penetration of high-speed
internet has allowed the patients to quickly access medical facilities
remotely, hence creating a positive outlook for the market. All these
aforementioned factors are expected to propel the Egypt liver therapeutics
market over the forecast period.
DOWNLOAD FREE SAMPLE REPORT
Market
Segmentation
The Egypt
liver cancer therapeutics market is segmented by type, by therapy, by end
users, competitional landscape, and regional distribution. Based on type, the market is
differentiated between hepatocellular carcinoma, cholangiocarcinoma,
hepatoblastoma, and others. By therapy the market is bifurcated into targeted
therapy, radiation therapy, immunotherapy, chemotherapy, and others. Based on
end users the market is fragmented into hospitals & clinics, ambulatory
care centers, and others. The market analysis also studies the regional
segmentation to devise regional market segmentation, divided among Cario,
Alexandria, Giza Qalyubia, Port Said Suez, and Rest of Egypt
Company Profile
Roche Egypt LLC, Bayer Middle East FZE,
Eli Lilly and Company (Egypt), Merck Egypt, and Novartis Egypt, are the leading
market players responsible
for the growth of Egypt liver cancer therapeutics market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, volume in units, and CAGR for
2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, volume forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
·
Type
·
Therapy
·
End User
|
|
Regional scope
|
Cario, Alexandria, Giza Qalyubia, Port Said Suez, and Rest of
Egypt
|
|
Key companies profiled
|
Roche Egypt LLC, Bayer Middle East FZE, Eli Lilly and Company
(Egypt), Merck Egypt, and Novartis Egypt
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, Egypt Liver Cancer
Therapeutics Market has been segmented into following categories, in
addition to the industry trends which have also been detailed below:
- Egypt Liver Cancer Therapeutics
Market, By Type:
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Hepatoblastoma
- Others.
- Egypt Liver Cancer Therapeutics
Market, By Crop Therapy:
- Targeted Therapy
- Radiation Therapy
- Immunotherapy
- Chemotherapy
- Others
- Egypt Liver Cancer Therapeutics
Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
- Egypt Liver Cancer Therapeutics
Market, By Region:
o
Alexandria
o
Giza Qalyubia
o
Port Said Suez
o
Rest of Egypt
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in Egypt Liver Cancer Therapeutics
Market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Egypt Liver Cancer Therapeutics Market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at [email protected]